GlassScriptPhysician profile
Allen T Raphael
NPI 1770539801
$324,359.68
in general payments reported to CMS, 2019-2025
37 companies · $66K in 2025
The $66K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76K · 2020: $31K · 2021: $29K · 2022: $53K · 2023: $31K · 2024: $38K · 2025: $66K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $78K · Consulting Fee: $23K · Travel and Lodging: $20K · Food and Beverage: $7,070 · Honoraria: $5,200 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,000 · Education: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $78,112.50 |
| Consulting Fee | $22,696.25 |
| Travel and Lodging | $20,042.30 |
| Food and Beverage | $7,070.39 |
| Honoraria | $5,200.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,000.00 |
| Education | $316.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $186,220.06 | 2019-2025 | Grafix, Stravix, Grafix Pl |
| Kerecis Limited | $51,392.66 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Biotissue Holdings INC. | $50,770.04 | 2019-2020 | |
| Amniox Medical, INC. | $22,762.64 | 2019-2020 | |
| Melinta Therapeutics, LLC | $11,180.43 | 2019-2025 | Kimyrsa, Orbactiv |
| Stryker Corporation | $429.84 | 2021-2023 | N/A, Actishield, Augment Injectable |
| Osiris Therapeutics INC. | $230.55 | 2019 | |
| Integra Lifesciences Corporation | $144.78 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Davol INC. | $141.01 | 2024 | Arista Ah Flexitip |
| Wright Medical Technology, INC. | $131.22 | 2019 | |
| Paratek Pharmaceuticals, INC. | $107.21 | 2021-2024 | Nuzyra |
| Becton, Dickinson and Company | $106.84 | 2024 | Arista Ah Flexitip |
| Medtronic, INC. | $102.57 | 2025 | Intellis Adaptivestim |
| Solventum Corporation | $57.68 | 2024-2025 | Activ.A.C., V.A.C. Veraflo |
| Amgen INC. | $49.39 | 2024 | Krystexxa |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $45.49 | 2019 | |
| Polynovo North America LLC | $43.81 | 2023-2024 | Novosorb Btm |
| Hydrofera LLC | $43.48 | 2022-2024 | Hydrofera Blue |
| Tactile Systems Technology INC | $39.76 | 2021 | |
| Bioventus LLC | $34.87 | 2019 | |
| Aroa Biosurgery Incorporated | $34.57 | 2020 | |
| Acell, INC. | $27.03 | 2019 | |
| Geistlich Pharma, North America, INC. | $26.69 | 2021 | |
| Averitas Pharma INC. | $24.44 | 2023 | Qutenza |
| Convatec INC. | $22.54 | 2024 | |
| Ets Wound Care LLC | $21.69 | 2025 | Mirragen Advanced Wound Matrix |
| Treace Medical Concepts, INC. | $20.57 | 2025 | |
| Inari Medical, INC. | $19.65 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Paragon 28, INC. | $17.91 | 2024 | Apex 3d |
| Kci USA, INC. | $16.66 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.85 | 2019 | |
| Acera Surgical, INC. | $15.12 | 2022 | |
| Organogenesis INC. | $14.95 | 2019 | |
| Merck Sharp & Dohme LLC | $14.67 | 2019 | |
| Celularity INC. | $13.00 | 2019 | |
| Omeza LLC | $10.07 | 2024 | |
| Orthofix Medical, INC. | $9.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Raphael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.